The Global Health program at the Council on Foreign Relations (CFR) provides independent, evidence-based analysis and recommendations to help policymakers, practitioners, business leaders, journalists, and the public meet the health challenges of a globalized world. These challenges include infectious diseases such as COVID-19 and monkeypox that cross borders with easier trade and travel, the rapid increase in cancers, diabetes, and other noncommunicable diseases in working-age people in developing countries, and the emerging perils of antibiotic resistance and climate change. These changing health needs place new demands on international institutions and initiatives at a time when their long-term financing is in doubt. Through rigorous research, articles, and online-interactives, CFR's experts work to advance evidence-based analysis and informed decision-making in global health.
China's ambitions for global health leadership are faltering as the COVID-19 pandemic persists. The country's mixed record of addressing the virus offers opportunities for U.S. global health leadership, writes Yanzhong Huang.
Rapid advancements in biotechnology could have massive implications for public health and the global economy. Ryan Morhard, director of policy and partnerships at Ginkgo Bioworks, outlines how global health security governance can keep pace.
Every viral pandemic since 1900 has been the result of spillover from animals to humans. Public health systems should take the steps outlined by Jay Varma and Neil Vora to limit the potential for spillover and the rapid spread of pathogens.